Arkolith/Insider Trading/ABOS/Form 4

Meisner Derek M

Chief Legal Officer & Corp SecAcumen Pharmaceuticals, Inc. (ABOS) · full profile →Form 4 · filed Jan 12, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$91K
Net Open-Market Flow
-$91K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 12, 2026Sell(S)9K$1.71$15K84K
Jan 9, 2026Sell(S)5K$1.76$9K92K
Jan 8, 2026Sell(S)30K$1.82$55K98K
Jan 8, 2026Sell(S)7K$1.82$12K128K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-001896) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML